Dividend King Growth Giant: J&J Faces Lilly Challenge
Johnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Using sentiment indicators with index level data combines psychology and price to strengthen analysis. This overview provides steps to integrate both streams.
26,363 articlesJohnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Greg Abel is moving Berkshire Hathaway beyond its familiar bets. After a bold $23 billion purchase in a single stock,...
Greg Abel, the man tapped to carry on Warren Buffett's investing legacy, is making a bold AI move with Alphabet. Berk...
Three energy-focused ETFs are delivering roughly 7% yields in 2026 while avoiding K-1 tax forms. They promise simpler...
The U.S. copper market, a roughly $20 billion arena, is flashing a breakout signal as cash costs go negative and by-p...
Dream Finders’ bid for Beazer has evolved into a live governance case, testing board discretion against shareholder r...
Swift moves from sandbox to live trial, coordinating tokenized deposits across 17 banks to speed cross-border settlem...
Anthropic and Airbnb are placing big bets on New York City, expanding footprints and hiring aggressively while critic...
A bold Independence Day plan envisions millions of U.S. kids gaining a financial stake in the economy, blending phila...
Analysts forecast a sizable 2027 COLA that could add about $98 to the average retiree's monthly Social Security benef...
NIO delivered a surprising Q4 2025 GAAP profit and outlined a 2026 path to positive non-GAAP earnings, supported by m...
As market volatility persists in mid-2026, five high-quality dividend stocks appear especially compelling for income ...